Sofinnova Ventures »

Spdr S&p 500 Etf shares owned by Sofinnova Ventures

Quarter-by-quarter ownership of Spdr S&p 500 Etf (SPY) shares owned by Sofinnova Ventures from 13F filings

Historical chart of Sofinnova Ventures investment in Spdr S&p 500 Etf

Tip: Access up to 7 years of quarterly data

All positions including Spdr S&p 500 Etf held by Sofinnova Ventures consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Spdr S&p 500 Etf by Sofinnova Ventures

Quarter filed Position value Share count Share price at filing
2023-09-30 $21M 50k 427.48
2023-03-31 $82M 200k 409.39
2021-12-31 $48M 100k 474.96

More positions owned by Sofinnova Ventures

Karuna Therapeutics Ord
Natera (NTRA)
AstraZeneca Sponsored Adr (AZN)
Merck & Co (MRK)
Ascendis Pharma A/S Sponsored Adr (ASND)
Rayzebio
Dex (DXCM)
Aerovate Therapeutics (AVTE)
Intuitive Surgical (ISRG)
Vera Therapeutics Cl A (VERA)
Cytokinetics (CYTK)
Elanco Animal Health (ELAN)
IShares TR Russell 2000 Etf Put Option (IWM)
argenx SE Sponsored Adr (ARGX)
Exelixis Put Option (EXEL)

View all positions for Sofinnova Ventures

Top funds holding Spdr S&p 500 Etf

Citadel Advisors
Susquehanna International
Goldman Sachs Group
Bank of America Corporation
Jpmorgan Chase & Co
Wolverine Trading
Millennium Management
Royal Bank of Canada
HBK Investments
Barclays
Wells Fargo & Company
Walleye Trading Advisors
UBS Group
Gts Securities
Bank Of Montreal

View all funds holding Spdr S&p 500 Etf